Prediction Prediction of the Insecticidal Potency of Biduri Plants (Calotropis gigantea) using the PASS online web resource
Life Science and Biotechnology · 2024
DOI: 10.19184/lsb.v2i1.47444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science and Biotechnology, 2024. Verfasst von Fahma Wardah Sururin und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Calotropis gigantea, a wild plant thriving in arid environments, has been traditionally used for medicinal purposes by communities near Baluran National Park (BNP). The latex of C. gigantea is used as a crab poison due to its ability to cause fatal damage and separation of body parts, possibly related to chitin disruption in insects. This study explores the potential insecticidal properties of secondary metabolites in C. gigantea using Prediction of Activity Spectra for Substance (PASS) Online. Out of 68 identified secondary metabolites, six show significant insecticidal potential, namely Profenophos, Ethion, Alpha-Citral, 1-Phenylethyl acetate, (E)-dec-3-en-2-one, and Benzaldehyde. Notably, Profenophos, Ethion, Alpha-Citral, and Benzaldehyde exhibit toxic properties effective against insects, with enzyme inhibitory activity affecting nerve signaling and immune systems, suggesting potential for bio-insecticide development.
Zitieren
APA
Sururin, F. W., & Khafiyya, N. A. (2024). Prediction Prediction of the Insecticidal Potency of Biduri Plants (Calotropis gigantea) using the PASS online web resource. Life Science and Biotechnology. https://doi.org/10.19184/lsb.v2i1.47444
Vancouver
Sururin FW, Khafiyya NA. Prediction Prediction of the Insecticidal Potency of Biduri Plants (Calotropis gigantea) using the PASS online web resource. Life Science and Biotechnology. 2024. doi:10.19184/lsb.v2i1.47444
BibTeX
@article{Sururin2024,
author = {Sururin, Fahma Wardah and Khafiyya, Nida An},
title = {Prediction Prediction of the Insecticidal Potency of Biduri Plants (Calotropis gigantea) using the PASS online web resource},
journal = {Life Science and Biotechnology},
year = {2024},
doi = {10.19184/lsb.v2i1.47444}
}
EUVIMED